China SXT Pharmaceuticals, Inc.

SXTC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001723980

SEC filings (opens in a new tab)

No open-market purchases or sales by China SXT Pharmaceuticals, Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $6 in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding China SXT Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of SXTC: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	5	6	+1
Shares	257.6K	236.8K	−20.8K (−8.1%)
Value	$138.9K	$65.5K	−$73.4K (−52.8%)

New holders (2)

Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to SXTC in Q1 2023
Institution	Shares	Value	% of portfolio
Renaissance Technologies LLC	34,500	$10.0K	0.00%
Citadel Advisors LLC	24,410	$7.02K	0.00%

Sold out (1)

Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of SXTC in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Millennium Management LLC	67,648	$37.0K